List of works - Gentian Denas

A Bridging Protocol in High-Thrombotic Risk Mechanical Valve Bearers Undergoing Surgery or Invasive Procedures

scientific article published on 01 December 2016

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation ⬇️

scientific article published on 28 December 2015

APS - Diagnostics and challenges for the future.

scientific article published on 31 July 2016

An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions

scientific article published on 14 October 2014

An unusual acute coronary syndrome: undisclosed disease hidden under a confounding clinical presentation

scientific article published on 06 April 2011

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

scientific article published on 01 May 2015

Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

scientific article published on 26 May 2011

Antiphospholipid syndrome and the heart: a case series and literature review

scientific article

Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk

scientific article published on 05 March 2015

Antiphospholipid syndrome: critical analysis of the diagnostic path

scientific article published on 01 April 2010

Cancer as a risk factor for stroke in atrial fibrillation patients receiving long-term oral anticoagulant therapy

scientific article published on 19 June 2015

Cancer prevention and vitamin K antagonists: an overview

scientific article published on April 2010

Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndrome

scientific article published on 01 June 2012

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile.

scientific article published in August 2013

Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation

scientific article published on 20 July 2017

Correct laboratory approach to APS diagnosis and monitoring.

scientific article published on 03 December 2012

Diagnosis and therapy of antiphospholipid syndrome

scientific article published on 26 August 2015

Dyspnoea in a young woman: the opposite of every truth is just as true

scientific article

Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.

scientific article published on 13 March 2008

Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study.

scientific article published on 18 September 2017

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

scientific article published on 13 October 2015

Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant

scientific article published on 22 October 2014

Interpretation of laboratory data and need for reference laboratories.

scientific article

Investigational anticoagulants for hematological conditions: a new generation of therapies.

scientific article published on 22 July 2013

Laboratory Diagnostics of Antiphospholipid Syndrome

scientific article published on 3 May 2017

Laboratory testing for antiphospholipid syndrome

scientific article published on 9 May 2016

Long-term use of vitamin K antagonists and incidence of cancer: a population-based study

scientific article published on 02 December 2010

Lupus Anticoagulant Testing: Diluted Russell Viper Venom Time (dRVVT).

scientific article published in January 2017

Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.

scientific article published on 24 March 2015

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

scientific article published in August 2010

Primary thromboprophylaxis with low-dose aspirin and antiphospholipid antibodies: Pro's and Con's.

scientific article published on 11 September 2017

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

scientific article published on 12 July 2018

Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.

scientific article published on 26 May 2009

The Three Players of Mechanical Valve Thrombosis: Cancer, Anticancer Therapy, and Thromboprophylaxis.

scientific article published in July 2016

The paradox of the lupus anticoagulant: history and perspectives.

scientific article published on 11 November 2014

The role of platelets in antiphospholipid syndrome

scientific article

Thrombocytopenia in high-risk patients with antiphospholipid syndrome

scientific article published on 8 January 2018

To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort.

scientific article published on 21 April 2015

Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure

scientific article published on 30 October 2020

Vitamin K to correct overanticoagulation

Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2 DS2 VASc 1 or 2): A treatment dilemma

scientific article published on 27 October 2017

What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?

scientific article published on 07 March 2012

List of works by Gentian Denas

A Bridging Protocol in High-Thrombotic Risk Mechanical Valve Bearers Undergoing Surgery or Invasive Procedures

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation ⬇️

APS - Diagnostics and challenges for the future.

An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions

An unusual acute coronary syndrome: undisclosed disease hidden under a confounding clinical presentation

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Antiphospholipid syndrome and the heart: a case series and literature review

Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk

Antiphospholipid syndrome: critical analysis of the diagnostic path

Cancer as a risk factor for stroke in atrial fibrillation patients receiving long-term oral anticoagulant therapy

Cancer prevention and vitamin K antagonists: an overview

Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndrome

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile.

Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation

Correct laboratory approach to APS diagnosis and monitoring.

Diagnosis and therapy of antiphospholipid syndrome

Dyspnoea in a young woman: the opposite of every truth is just as true

Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.

Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study.

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant

Interpretation of laboratory data and need for reference laboratories.

Investigational anticoagulants for hematological conditions: a new generation of therapies.

Laboratory Diagnostics of Antiphospholipid Syndrome

Laboratory testing for antiphospholipid syndrome

Long-term use of vitamin K antagonists and incidence of cancer: a population-based study

Lupus Anticoagulant Testing: Diluted Russell Viper Venom Time (dRVVT).

Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

Primary thromboprophylaxis with low-dose aspirin and antiphospholipid antibodies: Pro's and Con's.

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.

The Three Players of Mechanical Valve Thrombosis: Cancer, Anticancer Therapy, and Thromboprophylaxis.

The paradox of the lupus anticoagulant: history and perspectives.

The role of platelets in antiphospholipid syndrome

Thrombocytopenia in high-risk patients with antiphospholipid syndrome

To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort.

Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure

Vitamin K to correct overanticoagulation

Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2 DS2 VASc 1 or 2): A treatment dilemma

What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?